Martingale Asset Management’s Ginkgo Bioworks DNA Stock Holding History
Bought
Maintained
Sold
Other funds holding DNA
Martingale Asset Management's DNA Position: Q3 2026 in Review
Martingale Asset Management increased its Ginkgo Bioworks (DNA) stake by 0.14% in Q3 2026, buying an estimated $236 and bringing the position to 21,125 shares worth $271K. The position accounts for 0.01% of the portfolio, ranked #763.
Martingale Asset Management first reported a position in DNA in Q1 2026 and has held it in 3 quarters since. 185 funds tracked by Wall St. Rank hold DNA as of Q3 2026.
- Martingale Asset Management held 21,125 shares of Ginkgo Bioworks worth $271K as of Q3 2026.
- Martingale Asset Management bought 29 Ginkgo Bioworks shares in Q3 2026, an estimated $236.
- Ginkgo Bioworks made up 0.01% of Martingale Asset Management's portfolio in Q3 2026, its #763 holding.
- Martingale Asset Management first reported a position in Ginkgo Bioworks in Q1 2026 and has held it in 3 quarters since.
- 185 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q3 2026.
Based on Martingale Asset Management's 13F filing for Q3 2026, filed 12 Nov 2026.